# Clinical Study of Gastric Cancer, Colorectal Cancer and Bladder Cancer Based on Liquid Biopsy

> **NCT04385316** · — · UNKNOWN · sponsor: **The First Affiliated Hospital with Nanjing Medical University** · enrollment: 3 (estimated)

## Conditions studied

- Gastric Cancer
- Colorectal Cancer
- Bladder Cancer

## Interventions

- **DIAGNOSTIC_TEST:** DNA extraction of samples and high-throughput sequencing of small panels
- **DIAGNOSTIC_TEST:** DNA extraction of samples and high-throughput sequencing of small panels
- **DIAGNOSTIC_TEST:** DNA extraction of samples and high-throughput sequencing of small panels

## Key facts

- **NCT ID:** NCT04385316
- **Lead sponsor:** The First Affiliated Hospital with Nanjing Medical University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-09-01
- **Primary completion:** 2020-12-31
- **Final completion:** 2020-12-31
- **Target enrollment:** 3 (ESTIMATED)
- **Last updated:** 2020-05-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04385316

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04385316, "Clinical Study of Gastric Cancer, Colorectal Cancer and Bladder Cancer Based on Liquid Biopsy". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04385316. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*